Literature DB >> 33939598

Integration of Equipoise into Eligibility Criteria in the STARRT-AKI Trial.

Ron Wald1, Sean M Bagshaw2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33939598     DOI： 10.1164/rccm.202009-3425LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   30.528


× No keyword cloud information.
  1 in total

1.  A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial.

Authors:  Fernando G Zampieri; Bruno R da Costa; Suvi T Vaara; François Lamontagne; Bram Rochwerg; Alistair D Nichol; Shay McGuinness; Danny F McAuley; Marlies Ostermann; Ron Wald; Sean M Bagshaw
Journal:  Crit Care       Date:  2022-08-25       Impact factor: 19.334
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.